Literature DB >> 22472745

Effect of dyspepsia on survival: a longitudinal 10-year follow-up study.

Alexander C Ford1, David Forman, Alastair G Bailey, Anthony T R Axon, Paul Moayyedi.   

Abstract

OBJECTIVES: Most chronic and recurrent gastrointestinal (GI) symptoms in the community are caused by functional GI disorders, such as functional dyspepsia and irritable bowel syndrome (IBS). It is not known, however, whether these conditions affect mortality. We present the results of a large community-based prospective study that examines this issue.
METHODS: This was a 10-year follow-up, conducted in 2004, of individuals recruited into a community-based screening program for Helicobacter pylori. Data on mortality and cause of death at 10 years were obtained from the Office for National Statistics. Baseline demographic data, lifestyle factors, GI symptoms, and quality of life were recorded at study entry. The effect of all these factors on 10-year mortality was examined using univariate analysis and multivariate Cox regression analysis. All results were expressed as hazard ratios (HRs) with 99% confidence intervals (CIs).
RESULTS: Symptom data were available for 8,323 (99.0%) of 8,407 individuals originally enrolled, comprising over 84,000 years of follow-up: 3,169 (38.1%) subjects had dyspepsia, and 264 (3.2%) IBS. There were 137 (1.65%) individuals who had died at 10 years. After multivariate analysis, there was no significant difference in likelihood of death at 10 years in those with dyspepsia (HR: 0.94; 99% CI: 0.58-1.54) or IBS (HR: 1.35; 99% CI: 0.36-5.10), compared with those not meeting the criteria for either condition.
CONCLUSIONS: Dyspepsia was not associated with an increased mortality in the community. Data for any effect of IBS on survival were less clear. Further studies are required to assess the impact of functional GI disorders on life expectancy.

Entities:  

Mesh:

Year:  2012        PMID: 22472745     DOI: 10.1038/ajg.2012.69

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  25 in total

Review 1.  ACG and CAG Clinical Guideline: Management of Dyspepsia.

Authors:  Paul Moayyedi; Brian E Lacy; Christopher N Andrews; Robert A Enns; Colin W Howden; Nimish Vakil
Journal:  Am J Gastroenterol       Date:  2017-06-20       Impact factor: 10.864

2.  Initial management of dyspepsia in primary care: an evidence-based approach.

Authors:  Saqib Ansari; Alexander C Ford
Journal:  Br J Gen Pract       Date:  2013-09       Impact factor: 5.386

3.  Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndrome.

Authors:  Ruchit Sood; Alexander C Ford
Journal:  Ther Adv Chronic Dis       Date:  2013-11       Impact factor: 5.091

4.  Offshore training in navy personnel is associated with uninvestigated dyspepsia.

Authors:  Fan Li; Gang Sun; Yun-Sheng Yang; Li-Hong Cui; Li-Hua Peng; Xu Guo; Wei-Feng Wang; Bin Yan; Lanjing Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-12-06

Review 5.  Treatment of abdominal pain in irritable bowel syndrome.

Authors:  Tim Vanuytsel; Jan F Tack; Guy E Boeckxstaens
Journal:  J Gastroenterol       Date:  2014-05-21       Impact factor: 7.527

Review 6.  A comprehensive review of functional dyspepsia in pediatrics.

Authors:  Shamaila Waseem; Logan Rubin
Journal:  Clin J Gastroenterol       Date:  2021-12-02

7.  Five-year follow-up of 263 cases of functional bowel disorder.

Authors:  Yu-Rong Tang; Ping Wang; Rui Yin; Jian-Xin Ge; Guo-Pin Wang; Lin Lin
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

Review 8.  Helicobacter pylori infection in functional dyspepsia.

Authors:  Hidekazu Suzuki; Paul Moayyedi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-29       Impact factor: 46.802

Review 9.  Functional Dyspepsia: Diagnostic and Therapeutic Approaches.

Authors:  Gregory S Sayuk; C Prakash Gyawali
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

10.  Impact of microscopic duodenitis on symptomatic response to Helicobacter pylori eradication in functional dyspepsia.

Authors:  Seyed Sina Mirbagheri; Seyed Amir Mirbagheri; Behnam Nabavizadeh; Pouya Entezari; Mohammad Reza Ostovaneh; Seyed Mahmood Eshagh Hosseini; Nasser Rakhshani; Hoda Safa
Journal:  Dig Dis Sci       Date:  2014-08-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.